help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 5, 2008
Molecular Endocrinology, doi:10.1210/me.2007-0574
A more recent version of this article appeared on August 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
22/8/1767    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Diefenbacher, M.
Right arrow Articles by Kassel, O.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diefenbacher, M.
Right arrow Articles by Kassel, O.

Submitted on December 21, 2007
Accepted on May 27, 2008

Restriction to Fos family members of Trip6-dependent co-activation and GR-dependent trans-repression of AP-1

Markus Diefenbacher, Sylwia Sekula, Christine Heilbock, Jana V. Maier, Margarethe Litfin, Hans van Dam, Marc Castellazzi, Peter Herrlich, and Olivier Kassel*

Forschungszentrum Karlsruhe (M.D., S.S., C.H., J.V.M., M.L., P.H., O.K.), Institute of Toxicology and Genetics, D-76021 Karlsruhe, Germany; Department of Molecular Cell Biology (H.vD.), Leiden University Medical Center, 2333AL Leiden, The Netherlands; Université de Lyon (M.C.), Inserm U-758, IFR128 Lyon-Gerland, France; Leibniz Institute of Age Research-Fritz-Lipmann-Institute (P.H.), D-07745 Jena, Germany

* To whom correspondence should be addressed. E-mail: Olivier.Kassel{at}itg.fzk.de.

The term AP-1 describes homodimeric and heterodimeric transcription factors composed of members of the Jun, Fos and CREB/ATF families of proteins. Distinct AP-1 dimers, like for instance the prototypical c-Jun:c-Fos and c-Jun:ATF2 dimers, are differentially regulated by signaling pathways, and bind related yet distinct response elements in the regulatory regions of AP-1 target genes. Little is known about the dimer specific regulation of AP-1 activity at the promoter of its target genes. We have previously shown that nTrip6, the nuclear isoform of the LIM domain protein Trip6, acts as an AP-1 co-activator. Moreover, nTrip6 is an essential component of glucocorticoid receptor (GR)-mediated trans-repression of AP-1, in that it mediates the tethering of GR to the promoter-bound AP-1. We now discovered a striking specificity of nTrip6 actions determined by the binding preference of its LIM domains. We show that nTrip6 interacts only with Fos family members. Consequently, nTrip6 is a selective co-activator for AP-1 dimers containing Fos. nTrip6 also assembles activated GR to c-Jun:c-Fos-driven promoters. Neither nTrip6 nor GR are recruited to a promoter occupied by c-Jun:ATF2. Thus, only Fos containing dimers are trans-repressed by GR. Thus, the dimer composition of AP-1 determines the mechanism of both the positive and negative regulation of AP-1 transcriptional activity. Interestingly, on a second level of action, GR represses the increase in transcriptional activity of c-Jun:ATF2 induced by JNK-dependent phosphorylation. This repression depends on GR-mediated induction of MAP kinase phosphatase 1 (MKP-1) expression, which results in JNK inactivation.


Key words: AP-1 • Trip6 • nTrip6 • glucocorticoid receptor • co-activator • trans-repression • MKP-1 • DUSP1

NURSA Molecule Pages Link:

Nuclear Receptors:   GR
Ligands:   Dexamethasone






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society